Mouse models of allergic asthma: acute and chronic allergen challenge

被引:313
作者
Nials, Anthony T. [1 ]
Uddin, Sorif [1 ]
机构
[1] GlaxoSmithKline Med Res Ctr, Resp Ctr Excellence Drug Discovery, Stevenage SG1 2NY, Herts, England
关键词
D O I
10.1242/dmm.000323
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Asthma is defined as a chronic inflammatory disease of the airways; however, the underlying physiological and immunological processes are not fully understood. Animal models have been used to elucidate asthma pathophysiology, and to identify and evaluate novel therapeutic targets. Several recent review articles (Epstein, 2004; Lloyd, 2007; Boyce and Austen, 2005; Zosky and Sly, 2007) have discussed the potential value of these models. Allergen challenge models reproduce many features of clinical asthma and have been widely used by investigators; however, the majority involve acute allergen challenge procedures. It is recognised that asthma is a chronic inflammatory disease resulting from continued or intermittent allergen exposure, usually via inhalation, and there has been a recent focus on developing chronic allergen exposure models, predominantly in mice. Here, we review the acute and chronic exposure mouse models, and consider their potential role and impact in the field of asthma research.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 85 条
[41]   Co-administration of vaccination with DNA encoding T cell epitope on the Der p and BCG inhibited airway remodeling in a murine model of chronic asthma [J].
Kim, Chi Hong ;
Ahn, Joong Hyun ;
Kim, Seung Joon ;
Lee, Sook-Young ;
Kim, Young Kyoon ;
Kim, Kwan Hyoung ;
Moon, Hwa Sik ;
Song, Jeong Sup ;
Park, Sung Hak ;
Kwon, Soon Seog .
JOURNAL OF ASTHMA, 2006, 43 (05) :345-353
[42]   Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma - A pilot study 164/rccm.200206-5250C [J].
Kips, JC ;
O'Connor, BJ ;
Langley, SJ ;
Woodcock, A ;
Kerstjens, HAM ;
Postma, DS ;
Danzig, M ;
Cuss, F ;
Pauwels, RA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (12) :1655-1659
[43]   Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma [J].
Kon, OM ;
Sihra, BS ;
Compton, CH ;
Leonard, TB ;
Kay, AB ;
Barnes, NC .
LANCET, 1998, 352 (9134) :1109-1113
[44]   The "classical" ovalbumin challenge model of asthma in mice [J].
Kumar, Rakesh K. ;
Herbert, Cristan ;
Foster, Paul S. .
CURRENT DRUG TARGETS, 2008, 9 (06) :485-494
[45]   Reversibility of airway inflammation and remodelling following cessation of antigenic challenge in a model of chronic asthma [J].
Kumar, RK ;
Herbert, C ;
Kasper, M .
CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (11) :1796-1802
[46]   Effects of anticytokine therapy in a mouse model of chronic asthma [J].
Kumar, RK ;
Herbert, C ;
Webb, DC ;
Li, L ;
Foster, PS .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (10) :1043-1048
[47]   Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma [J].
Kumar, RK ;
Herbert, C ;
Thomas, PS ;
Wollin, L ;
Beume, R ;
Yang, M ;
Webb, DC ;
Foster, PS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (01) :349-355
[48]   Modeling allergic asthma in mice - Pitfalls and opportunities [J].
Kumar, RK ;
Foster, PS .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 27 (03) :267-272
[49]   Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response [J].
Leckie, MJ ;
ten Brinke, A ;
Khan, J ;
Diamant, Z ;
O'Connor, BJ ;
Walls, CM ;
Mathur, AK ;
Cowley, HC ;
Chung, KF ;
Djukanovic, R ;
Hansel, TT ;
Holgate, T ;
Sterk, PJ ;
Barnes, PJ .
LANCET, 2000, 356 (9248) :2144-2148
[50]   Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma [J].
Lee, Sook Young ;
Kim, Jin Sook ;
Lee, Jung Mi ;
Kwon, Soon Seok ;
Kim, Kwan Hyung ;
Moon, Hwa Sik ;
Song, Jung Sub ;
Park, Sung Hark ;
Kim, Young Kyoon .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (01) :14-19